Permeability of the blood-brain barrier in normal appearing white and grey matter predicts early inadequate treatment response to fingolimod og natalizumab

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2016
This article has no abstract
Epistemonikos ID: 54cafb2f21070cb1632d716ed49b32e9f5f55768
First added on: Apr 29, 2026